Friday, Oct 16, 2026

"anti-diabetes-drug"

AstraZeneca gets marketing authorisation to use anti-diabetes drug for kidney disease

The study results of dapagliflozin showed significant benefits in reducing CKD progression in patients with and without type-2 diabetes.

Latest News

‘Didn’t want to awaken the Kumbha’: Rajamouli’s birthday message for Prithviraj

8 minutes ago
Bhuvneshwar Kumar added to India squad for fifth T20I against West Indies

16 minutes ago
160 young cricketers to compete in inaugural Test Twenty tournament in Sri Lanka

23 minutes ago
Janhvi Kapoor, Sreeleela and Siddharth Gupta’s romantic thriller goes on floors in Nainital

24 minutes ago
Smriti Mandhana calls captaincy a huge honour, stresses responsibility

41 minutes ago
Cyberabad Police issue home safety advisory as families leave for Navaratri

46 minutes ago
Democracy does not end after polls, says CJP founder Abhijeet Dipke

52 minutes ago
Telangana and Karnataka are “two halves of one value chain”: Sridhar Babu at Bengaluru Roadshow

54 minutes ago